Coronavirus (COVID-19) News and Resources
Coronavirus (COVID-19) Webcasts
Subscribe to Free Daily Newsletters
Post a Job

Featured Jobs

Defined Contribution Account Manager
Nova 401(k) Associates logo
Nova 401(k) Associates
(Houston TX / Dallas TX / Scottsdale AZ / Telecommute)
Retirement Plan Processor
T Bank NA
(Dallas TX)
ESOP Valuation Writer
Unique ESOP Valuation Provider

Free Daily News and Jobs

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Get the BenefitsLink app LinkedIn

<< Previous news item   |   Next news item >>

Public Employee Plan Takes Sovaldi Cost to Court
Healthcare Payer News Link to more items from this source
Dec. 11, 2014
"[The] mass transit provider for greater Philadelphia [Septa], is suing Gilead Sciences, the maker of the Hepatitis-C drug Sovaldi, for excessive pricing -- the first such lawsuit.... Septa has a workforce of around 9,000, with many more covered in a health plan for retirees, and says it has spent $2.4 million on Sovaldi through the first 11 months of the year. Gilead has charged far more than it needs to, argue lawyers for Septa ... The drug company is attempting 'to exploit the patent laws by selectively charging exorbitant prices,' [according to] a complaint filed in federal court in Philadelphia."

Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the link above).
An important word about authorship: BenefitsLink® is providing a hypertext link to the item shown above, but is not the author of the item (unless otherwise specified).
© 2020, Inc.